The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Abstract
Objectives: Analyze changes that have occurred among U.S. hospitals over a 17-year period, 1975 through 1991, in the percentage of Staphylococcus aureus resistant to b-lactam antibiotics and associated with nosocomial infections. Design: Retrospective review. The percentage of methicillin-resistant S aureus (MRSA) was defined as the number of S aureus isolates resistant to either methicillin, oxacillin, or nafcillin divided by the total number of S aureus isolates for which methicillin, oxacillin, or nafcillin susceptibility test results were reported to the National Nosocomial Infections Surveillance (NNIS) System. Setting: NNIS System hospitals. Results: Of the 66,132 S aureus isolates that were tested for susceptibility to methicillin, oxacillin, or nafcillin during 1975 through 1991, 6,986 (11%) were resistant to methicillin, oxacillin, or nafcillin. The percentage MRSA among all hospitals rose from 2.4% in 1975 to 29% in 1991, but the rate of increase differed significantly among 3 bed-size categories: <200 beds, 200 to 499 beds, and 2500 beds. In 1991, for hospitals with <200 beds, 14.9% of S aureus isolates were MRSA, for hospitals with 200 to 499 beds, 20.3% were MRSA; and for hospitals with >500 beds, 38.3% were MRSA. The percentage MRSA in each of the bed-size categories rose above 5% at different times: in 1983, for hospitals with 2500 beds; in 1985, for hospitals with 200 to 499 beds; and in 1987, for hospitals with <200 beds. Conclusions: This study suggests that hospitals of all sizes are facing the problem of MRSA, the problem appears to be increasing regardless of hospital size, and control measures advocated for MRSA appear to require re-evaluation. Further study of MRSA in hospitals would benefit our understanding of this costly pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
"Celbenin" - resistant Staphylococci
Jevons, M. P. (1961) · BMJ · doi:10.1136/bmj.1.5219.124-a · Cited by 1,680
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,425
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109
Self-citationGuideline for Isolation Precautions in Hospitals
Garner, J. S., & the Hospital Infection Control Practices Advisory Committee (1996) · Infection Control & Hospital Epidemiology · doi:10.1017/s0195941700006123 · Cited by 994
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880
Self-citationNational nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Self-citationEpidemiology of Nosocomial Infections Caused by Methicillin-Resistant Staphylococcus aureus
THOMPSON, R. L., CABEZUDO, I., & WENZEL, R. P. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-309 · Cited by 651
Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584
Cited by
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Kluytmans, J., van Belkum, A., & Verbrugh, H. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.505 · Cited by 2,595
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362
An overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286
Self-citationEmergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Zhang, K., McClure, J.-A., Elsayed, S., Louie, T., & Conly, J. M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5026-5033.2005 · Cited by 1,037
Shopsin, B., Gomez, M., Montgomery, S. O., Smith, D. H., Waddington, M., Dodge, D. E., Bost, D. A., Riehman, M., Naidich, S., & Kreiswirth, B. N. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.11.3556-3563.1999 · Cited by 984
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Methicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031
McDonald, L. C., Owings, M., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1203.051064 · Cited by 788
Moise-Broder, P. A., Forrest, A., Birmingham, M. C., & Schentag, J. J. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00005 · Cited by 757
Goldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 753
Boyce, J. M., Potter-Bynoe, G., Chenevert, C., & King, T. C. (1997) · Infection Control and Hospital Epidemiology · doi:10.2307/30141488 · Cited by 673
Epidemiology of Nosocomial Fungal Infections, with Emphasis on Candida Species
Jarvis, W. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1526 · Cited by 636
Klevens, R. M., Edwards, J. R., Tenover, F. C., McDonald, L. C., Horan, T., Gaynes, R., & System, N. N. I. S. (2006) · Clinical Infectious Diseases · doi:10.1086/499367 · Cited by 551
Self-citationStevens, D. L., Herr, D., Lampiris, H., Hunt, J. L., Batts, D. H., Hafkin, B., & the Linezolid MRSA Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/340353 · Cited by 506
Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases
Oliveira, D., Borges, A., & Simões, M. (2018) · Toxins · doi:10.3390/toxins10060252 · Cited by 485
The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals
Rubin, R. J., Harrington, C. A., Poon, A., Dietrich, K., Greene, J. A., & Moiduddin, A. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0501.990102 · Cited by 445
Rubinstein, E., Cammarata, S. K., Oliphant, T. H., Wunderink, R. G., & the Linezolid Nosocomial Pneumonia Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/318486 · Cited by 440
Graffunder, E. M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf009 · Cited by 411
Antimicrobial resistance in gram-positive bacteria
Rice, L. B. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.220 · Cited by 381
Diekema, D. J., & Jones, R. N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06964-1 · Cited by 378
The Progressive Intercontinental Spread of Methicillin-Resistant Staphylococcus aureus
Ayliffe, G. A. J. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s74 · Cited by 375
Naimi, T. S., LeDell, K. H., Boxrud, D. J., Groom, A. V., Steward, C. D., Johnson, S. K., Besser, J. M., O’Boyle, C., Danila, R. N., Cheek, J. E., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322693 · Cited by 369
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318535 · Cited by 369
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria
Medina, E., & Pieper, D. H. (2016) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2016_492 · Cited by 356
The Risk of Infection after Nasal Colonization with Staphylococcus Aureus
Safdar, N., & Bradley, E. A. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.07.034 · Cited by 348
Mechanisms of Antibiotic Resistance in Staphylococcus Aureus
Pantosti, A., Sanchini, A., & Monaco, M. (2007) · Future Microbiology · doi:10.2217/17460913.2.3.323 · Cited by 348
Angulo, F. J., Johnson, K. R., Tauxe, R. V., & Cohen, M. L. (2000) · Microbial Drug Resistance · doi:10.1089/mdr.2000.6.77 · Cited by 343
Moise-Broder, P. A., Sakoulas, G., Eliopoulos, G. M., Schentag, J. J., Forrest, A., & Moellering, R. C. (2004) · Clinical Infectious Diseases · doi:10.1086/421092 · Cited by 332
Jernigan, J. A., Titus, M. G., Groschel, D. H. M., Getchell-White, S. I., & Farr, B. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008770 · Cited by 317
Abramson, M. A., & Sexton, D. J. (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501641 · Cited by 314
Steinberg, J. P., Clark, C. C., & Hackman, B. O. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.2.255 · Cited by 311
Staphylococcus aureus–associated Skin and Soft Tissue Infections in Ambulatory Care
McCaig, L. F., McDonald, L. C., Mandal, S., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1211.060190 · Cited by 307
Pujol, M., Peña, C., Pallares, R., Ariza, J., Ayats, J., Dominguez, M. A., & Gudiol, F. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00014-9 · Cited by 289
Merrer, J., Santoli, F., Vecchi, C. A.-D., Tran, B., De Jonghe, B., & Outin, H. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501721 · Cited by 289
Fluit, A. C., Wielders, C. L. C., Verhoef, J., & Schmitz, F.-J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3727-3732.2001 · Cited by 287
Meticillin-resistant Staphylococcus aureus in animals: A review
Leonard, F. C., & Markey, B. K. (2008) · The Veterinary Journal · doi:10.1016/j.tvjl.2006.11.008 · Cited by 282
Significance and Biological Importance of Pyrimidine in the Microbial World
Sharma, V., Chitranshi, N., & Agarwal, A. K. (2014) · International Journal of Medicinal Chemistry · doi:10.1155/2014/202784 · Cited by 279
Guideline for Infection Control in Healthcare Personnel, 1998
Bolyard, E. A., Tablan, O. C., Williams, W. W., Pearson, M. L., Shapiro, C. N., Deitchman, S. D., & Hospital Infection Control Practices Advisory Committee (1998) · Infection Control & Hospital Epidemiology · doi:10.1086/647840 · Cited by 277
Antimicrobial Resistance in Gram-Positive Bacteria
Rice, L. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.012 · Cited by 276
Uehara, Y., Nakama, H., Agematsu, K., Uchida, M., Kawakami, Y., Abdul Fattah, A. S. M., & Maruchi, N. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.1999.0680 · Cited by 229
Discovery and development of a synthetic peptide derived from lactoferrin for clinical use
Brouwer, C. P. J. M., Rahman, M., & Welling, M. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.07.017 · Cited by 90
PATHOGENS RESISTANT TO ANTIMICROBIAL AGENTS
Fraimow, H. S., & Abrutyn, E. (1995) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30683-8 · Cited by 37
Reduction of Methicillin-Resistant Staphylococcus aureus Infection among Veterans in Atlanta
Stenehjem, E., Stafford, C., & Rimland, D. (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668776 · Cited by 14
Metadata
- Authors
- Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S.
- Venue
- Infection Control & Hospital Epidemiology
- Publisher
- Cambridge University Press (CUP)
- Published
- 1992-10
- Volume
- 13
- Issue
- 10
- Pages
- 582-586
- ISSN
- 0899-823X (ISSN-L)
- 1559-6834
- OpenAlex
- W2133043345
- Cited by
- 657
- References
- 31
- FWCI
- 14.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.